233
panel
Closing Plenary | Financing Sustainable Investment
panel
Public Finance Forum Reception
panel
Lunch Plenary | Lessons Learned: Policy for Economic Recovery in the Post-Pandemic Era
Soon it will be three years since the start of the COVID-19 pandemic, yet global economic recove
ry keeps stalling. Just a few of the challenges ahead are high inflation rates, the need to provide a social safety net, and employment.
+ Read More
panel
Global Debt Sustainability
Global debt levels are at historically high levels. Regardless of economic level, countries
around the world are now faced with a series of (to varying degrees) difficult choices.
+ Read More
panel
Networking Break
podcast episode
Ep. 125: Leadership, With BTG Pactual’s André Esteves
“We need to attack extreme poverty. Of course, the pandemic brought additional challenges to that.
But, we provided emergency aid for an extensive part of our population, around 60 million people.
+ Read More
panel
Defeating a Global Enemy: Collaboration Against Cancer
The COVID-19 pandemic has proved that global cooperation and public-private partnerships can suc
cessfully strive together in times of crisis to make a tangible impact.
+ Read More
panel
Transforming Healthcare: Technology, Innovation, and Going Digital
Over the last 18 months, few sectors have been so challenged and had to adapt more quickly than
health-care delivery and epidemiology.
+ Read More
panel
Tackling Type 1 Diabetes: Where the Science is Heading
Around the world, numbers of type 1 diabetes (T1D) cases are rising. It's expected that by 2050,
5 million people in the United States alone will have been diagnosed.
+ Read More
panel
Medical Supply Chains During the Pandemic: Lessons Learned and Best Practices
The COVID-19 pandemic tested US and global supply chains by requiring the production and distrib
ution of hundreds of millions of units of key medical products at unprecedented speed.
+ Read More
panel
The Give and Take of Drug Pricing Reform
Several proposals to lower drug costs have been introduced in recent years in response to growin
g public concern about drug prices and affordability.
+ Read More